Skip to main content
. 2020 Nov 10;21:469. doi: 10.1186/s12882-020-02141-9

Fig. 5.

Fig. 5

The cumulative frequency of a 50% reduction in proteinuria during the follow-up period. a. The accumulated effective rate for the two groups “IS therapy plus HCQ” and “conventional IS therapy”. b. The accumulated effective rate for each group in the “IS therapy plus HCQ” group. Group A: Patients treated with corticosteroid plus immunosuppressive agents before HCQ therapy. Group B: Patients treated with corticosteroid only before HCQ therapy